Plain-English translation of NCT05332067 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , a medication that works by calming your immune system's allergic response. Researchers want to see if giving children a single dose of this medication right when they catch a cold in the fall can stop asthma flare-ups from happening. The study will track how well the body fights off the cold and whether fewer asthma emergencies occur.
Many children with asthma get their worst flare-ups when they catch colds, especially in the fall when kids return to school. Doctors want to know if giving this medication early โ at the very first sign of a cold โ can prevent those scary asthma attacks from developing.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will first spend 2โ6 months working with the study team to get your asthma well-controlled with regular medicines and check-ins every 1โ2 months. Then, during the fall school season, you will watch for signs of a cold (runny nose, congestion, or sneezing). As soon as a cold starts, you'll come in for a visit where doctors will confirm you have a cold and give you either the study medication or a placebo (fake medicine). The study team will collect a small nasal sample to measure how your body is fighting the cold, and they'll track whether you develop an asthma flare-up over the next week.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
United States